Apronalide

DB13221ApprovedSmall molecule

Apronalide is approved in Japan. Apronalide has been withdrawn from the market in many other countries due to patient development of thrombocytopenic purpura .

Chemical structure of Apronalide
Formula / weight
C9H16N2O2 · 184.239 g/mol (avg)
Also known as
Apronal

Resolves to

Compound
UNIIV18J24E25ECAS528-92-7ChEMBLCHEMBL509282ChEBI134827
Clinical / RWD
ATCN05CM12
Structure
InChIKeyKSUUMAWCGDNLFK-UHFFFAOYSA-NSMILESCC(C)C(CC=C)C(=O)NC(N)=O

What you can answer from here — as of April 02, 2025

668Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 5 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Apronalide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In